PL435967A1 - Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnika - Google Patents

Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnika

Info

Publication number
PL435967A1
PL435967A1 PL435967A PL43596720A PL435967A1 PL 435967 A1 PL435967 A1 PL 435967A1 PL 435967 A PL435967 A PL 435967A PL 43596720 A PL43596720 A PL 43596720A PL 435967 A1 PL435967 A1 PL 435967A1
Authority
PL
Poland
Prior art keywords
ovarian cancer
diagnosis
vitro
mirna biomarkers
diagnostic test
Prior art date
Application number
PL435967A
Other languages
English (en)
Other versions
PL243444B1 (pl
Inventor
Magdalena NIEMIRA
Anna EROL
Adam Jacek Krętowski
Original Assignee
Uniwersytet Medyczny W Białymstoku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US18/252,634 priority Critical patent/US20240002949A1/en
Application filed by Uniwersytet Medyczny W Białymstoku filed Critical Uniwersytet Medyczny W Białymstoku
Priority to PL435967A priority patent/PL243444B1/pl
Priority to CA3198479A priority patent/CA3198479A1/en
Priority to AU2021378868A priority patent/AU2021378868A1/en
Priority to PCT/PL2021/050079 priority patent/WO2022103287A1/en
Priority to EP21840201.4A priority patent/EP4244393A1/en
Publication of PL435967A1 publication Critical patent/PL435967A1/pl
Publication of PL243444B1 publication Critical patent/PL243444B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Przedmiotem niniejszego wynalazku jest zestaw biomarkerów miRNA do diagnostyki in vitro raka jajnika, sposób diagnozowania in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA do diagnozowania in vitro raka jajnika, w diagnostycznym badaniu przesiewowym in vitro pod kątem występowania raka jajnika, do oceny skuteczności leczenia raka jajnika, do monitorowania odpowiedzi na leczenie raka jajnika oraz do przewidywania wznowy raka jajnika po ukończonym leczeniu raka jajnika, jak również test do diagnostyki in vitro raka jajnika.
PL435967A 2020-11-12 2020-11-12 Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika PL243444B1 (pl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US18/252,634 US20240002949A1 (en) 2020-11-12 2020-11-11 Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer
PL435967A PL243444B1 (pl) 2020-11-12 2020-11-12 Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika
CA3198479A CA3198479A1 (en) 2020-11-12 2021-11-11 Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer
AU2021378868A AU2021378868A1 (en) 2020-11-12 2021-11-11 Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer
PCT/PL2021/050079 WO2022103287A1 (en) 2020-11-12 2021-11-11 Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer
EP21840201.4A EP4244393A1 (en) 2020-11-12 2021-11-11 Panel of mirna biomarkers for diagnosis of ovarian cancer, method for in vitro diagnosis of ovarian cancer, uses of panel of mirna biomarkers for in vitro diagnosis of ovarian cancer and test for in vitro diagnosis of ovarian cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL435967A PL243444B1 (pl) 2020-11-12 2020-11-12 Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika

Publications (2)

Publication Number Publication Date
PL435967A1 true PL435967A1 (pl) 2022-05-16
PL243444B1 PL243444B1 (pl) 2023-08-28

Family

ID=79287850

Family Applications (1)

Application Number Title Priority Date Filing Date
PL435967A PL243444B1 (pl) 2020-11-12 2020-11-12 Diagnostyczny zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania takiego zestawu biomarkerów miRNA oraz zestaw testowy do diagnostyki in vitro raka jajnika

Country Status (6)

Country Link
US (1) US20240002949A1 (pl)
EP (1) EP4244393A1 (pl)
AU (1) AU2021378868A1 (pl)
CA (1) CA3198479A1 (pl)
PL (1) PL243444B1 (pl)
WO (1) WO2022103287A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250174355A1 (en) * 2022-07-04 2025-05-29 Artificial Intelligence Expert Srl Method and system for multi-cancer management in subject
GB2623570B (en) * 2022-10-21 2025-07-23 Wobble Genomics Ltd Method and products for biomarker identification
CN117838868A (zh) * 2024-03-04 2024-04-09 暨南大学 miR-103-3p在ADSCs移植中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2354246A1 (en) * 2010-02-05 2011-08-10 febit holding GmbH miRNA in the diagnosis of ovarian cancer
US11214839B2 (en) * 2017-01-09 2022-01-04 Dana-Farber Cancer Institute, Inc. Circulating microRNA signatures for ovarian cancer
CA3059480A1 (en) * 2017-04-28 2018-11-01 Toray Industries, Inc. Kit, device, and method for detecting ovarian tumor
CN111826466B (zh) * 2020-07-31 2021-06-29 南方医科大学深圳医院 乙型肝炎感染患者或携带者外泌体miRNA分子标志物组合及筛查试剂盒

Also Published As

Publication number Publication date
WO2022103287A4 (en) 2022-07-07
WO2022103287A1 (en) 2022-05-19
EP4244393A1 (en) 2023-09-20
PL243444B1 (pl) 2023-08-28
AU2021378868A1 (en) 2023-06-15
US20240002949A1 (en) 2024-01-04
CA3198479A1 (en) 2022-05-19
AU2021378868A9 (en) 2025-01-09

Similar Documents

Publication Publication Date Title
PL435967A1 (pl) Zestaw biomarkerów miRNA do diagnostyki raka jajnika, sposób diagnostyki in vitro raka jajnika, zastosowania zestawu biomarkerów miRNA oraz test do diagnostyki in vitro raka jajnika
MX2018013621A (es) Metodo, matriz y uso de estos.
MX2019008911A (es) Metodos, matrices y usos de estos.
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
GB201207297D0 (en) Analytical methods and arrays for use in the same
WO2014201516A3 (en) Biomarker identification
EP3751283A3 (en) Blood-based screen for detecting neurological diseases in primary care settings
NZ629074A (en) Biomarkers for gastric cancer and uses thereof
EA201290311A1 (ru) Факторы риска и прогнозирование инфаркта миокарда
CL2017001972A1 (es) Biomarcadores para cáncer pancreático
CY1119262T1 (el) Αναλυτικες μεθοδοι και συστοιχιες για χρηση στην ταυτοποιηση παραγοντων που επαγουν ευαισθητοποιηση στο ανθρωπινο δερμα
MX383381B (es) Métodos y composiciones para detectar proteínas mal plegadas.
GB2509682A (en) Biomarkers useful for detection of tyres, grades and stages of human breast cancer
BR112017006315A2 (pt) agente terapêutico, uso de um agente terapêutico, métodos in vitro para determinar se um sujeito com melanoma tem um risco maior de desenvolver metástase, de determinação de um regime de tratamento para um sujeito que sofre de melanoma, de tratamento de um sujeito que sofre de melanoma, ensaio in vitro para predizer o risco aumentado de metástase e kits
MX2020002788A (es) Biomarcadores de preeclampsia y sistemas y metodos relacionados.
MX374601B (es) Procedimientos y series para su uso en los mismos.
GB201009798D0 (en) Method,array and use thereof
BR112018073214A2 (pt) métodos para a previsão do risco de recorrência da fibrilação atrial, para o diagnóstico de fibrilação atrial em um indivíduo, para o monitoramento de uma terapia e para a classificação da fibrilação e utilizações do biomarcador
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos
GB201206323D0 (en) Methods and arrays for use in the same
MX2015011804A (es) Metodos y composiciones para diagnosticar preeclampsia.
WO2018208122A8 (ko) 담도 세포에서 메티오닐-타알엔에이 합성효소를 이용한 담도암 진단 방법
ZA202106673B (en) Salivary biomarkers of brain injury